HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish Caucasian populations

被引:80
作者
Trachtenberg, EA
Yang, H
Hayes, E
Vinson, M
Lin, C
Targan, SR
Tyan, D
Erlich, H
Rotter, JI
机构
[1] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA
[2] Cedars Sinai Med Ctr, Steven Spielberg Pediat Res Ctr, Div Med Genet & Gastroenterol, Ctr Inflammatory Bowel Dis,Dep Med, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Steven Spielberg Pediat Res Ctr, Div Med Genet & Gastroenterol, Ctr Inflammatory Bowel Dis,Dept Pediat, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Div Med Genet, Los Angeles, CA 90048 USA
[5] Roche Mol Syst, Dept Human Genet, Alameda, CA USA
关键词
IBD; Crohn's disease; ulcerative colitis; HLA class II association;
D O I
10.1016/S0198-8859(99)00134-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis (UC) and Crohn's disease (CD) are the clinical entities comprising idiopathic inflammatory bowel disease (IBD). Previous studies on the association of IBD anti human leukocyte antigen (HLA) class II genes suggested a role for HLA in this disease. Here we present HLA class II (DRB1, DQB1, DQA1, DPB1) allele and haplotype distributions determined using the polymerase chain reaction and sequence-specific oligonucleotide probe methods. A total of 578 UC and CD Caucasian patients and controls from Jewish (Ashkenazi) and non-Jewish populations was examined. Our previously reported association of DR1-DQ5 with CD was attributable to DRB1*0103. A dramatic association with IDD and the highly unusual DRB1*0103-DQA1*0501-DQB1*0301 haplotype (OR = 6.6, p = 0.036) was found. The more common DR1 haplotype, DRB1*0103-DQA1*0101-DQB1*0501, was also associated with IBD (OR = 3.1, p = 0.014), a result suggesting that interaction between DR and DQ may determine the extent of disease risk. Our previously reported association of DR2 with UC was attributable to DRB1*1502 (OR = 2.6, p = 0.006). At the DPB1 locus, a significant association of DPB1*0401 with CD was observed fur the combined populations (OR = 1.85, p = 0.007). These observations indicate that some class II alleles and haplotypes confer susceptibility to both UC and CD, implying common immunogenetic mechanisms of pathogenesis, while others conics risk to only one of these diseases, and illustrate the value of DNA HLA typing in disease susceptibility analyses. (C) American Society fur Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 42 条
[1]  
ANDUS T, 1995, GASTROENTEROLOGY, V108, pA770
[2]  
ANNESE V, 1995, GASTROENTEROLOGY, V108, pA771
[3]  
[Anonymous], 1982, CASE CONTROL STUDIES
[4]  
BEGOVICH AB, 1992, J IMMUNOL, V148, P249
[5]   Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD) [J].
Bouma, G ;
Pool, MO ;
Crusius, JBA ;
Schreuder, GMT ;
Hellemans, HPR ;
Meijer, BUGA ;
Kostense, PJ ;
Giphart, MJ ;
Meuwissen, SGM ;
Pena, AS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) :175-179
[6]   HLA-DRB1*03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease [J].
Bouma, G ;
Poen, AC ;
García-González, MA ;
Schreuder, GMT ;
Felt-Bersma, RJF ;
Meuwissen, SGM ;
Peña, AS .
IMMUNOGENETICS, 1998, 47 (06) :451-455
[7]   Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD) [J].
Bouma, G ;
Xia, B ;
Crusius, JBA ;
Bioque, G ;
Koutroubakis, I ;
VonBlomberg, BME ;
Meuwissen, SGM ;
Pena, AS .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (03) :391-396
[8]   Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease [J].
Bouma, G ;
Crusius, JBA ;
Pool, MO ;
Kolkman, JJ ;
VonBlomberg, BME ;
Kostense, PJ ;
Giphart, MJ ;
Schreuder, GMT ;
Meuwissen, SGM ;
Pena, AS .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) :456-463
[9]  
BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231
[10]  
Castro R., 1995, American Journal of Human Genetics, V57, pA161